Go Pro

Innovative Eyewear (LUCYW) Competitors

Innovative Eyewear logo
$0.04 0.00 (0.00%)
As of 08/21/2026 03:57 PM Eastern

LUCYW vs. NXGLW, WOK, MDLN, ALC, and WST

Should you buy Innovative Eyewear stock or one of its competitors? Innovative Eyewear's main competitors and comparable companies include NEXGEL (NXGLW), WORK Medical Technology Group (WOK), Medline (MDLN), Alcon (ALC), and West Pharmaceutical Services (WST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Innovative Eyewear compare to NEXGEL?

Innovative Eyewear (NASDAQ:LUCYW) and NEXGEL (NASDAQ:NXGLW) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

Company Net Margins Return on Equity Return on Assets
Innovative EyewearN/A N/A N/A
NEXGEL N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$3.41MN/AN/AN/AN/A
NEXGEL$12.07MN/AN/AN/AN/A

In the previous week, Innovative Eyewear and Innovative Eyewear both had 1 articles in the media. Innovative Eyewear's average media sentiment score of 0.88 beat NEXGEL's score of 0.00 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Innovative Eyewear
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NEXGEL
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Innovative Eyewear and NEXGEL tied by winning 1 of the 2 factors compared between the two stocks.

How does Innovative Eyewear compare to WORK Medical Technology Group?

WORK Medical Technology Group (NASDAQ:WOK) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Company Net Margins Return on Equity Return on Assets
WORK Medical Technology GroupN/A N/A N/A
Innovative Eyewear N/A N/A N/A

Innovative Eyewear has lower revenue, but higher earnings than WORK Medical Technology Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WORK Medical Technology Group$10.72MN/A-$1.07MN/AN/A
Innovative Eyewear$3.41MN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, WORK Medical Technology Group had 1 more articles in the media than Innovative Eyewear. MarketBeat recorded 2 mentions for WORK Medical Technology Group and 1 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 0.88 beat WORK Medical Technology Group's score of 0.44 indicating that Innovative Eyewear is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
WORK Medical Technology Group
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Innovative Eyewear
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

WORK Medical Technology Group beats Innovative Eyewear on 3 of the 4 factors compared between the two stocks.

How does Innovative Eyewear compare to Medline?

Innovative Eyewear (NASDAQ:LUCYW) and Medline (NASDAQ:MDLN) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

Medline has higher revenue and earnings than Innovative Eyewear.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$3.41MN/AN/AN/AN/A
Medline$28.43B1.58$1.16B$0.7943.37

Medline has a consensus target price of $47.42, indicating a potential upside of 38.42%. Given Medline's stronger consensus rating and higher possible upside, analysts plainly believe Medline is more favorable than Innovative Eyewear.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Medline
1 Sell rating(s)
5 Hold rating(s)
21 Buy rating(s)
2 Strong Buy rating(s)
2.83

Company Net Margins Return on Equity Return on Assets
Innovative EyewearN/A N/A N/A
Medline N/A N/A N/A

In the previous week, Medline had 15 more articles in the media than Innovative Eyewear. MarketBeat recorded 16 mentions for Medline and 1 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 0.88 beat Medline's score of 0.09 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Innovative Eyewear
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Medline
4 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Medline beats Innovative Eyewear on 6 of the 7 factors compared between the two stocks.

How does Innovative Eyewear compare to Alcon?

Innovative Eyewear (NASDAQ:LUCYW) and Alcon (NYSE:ALC) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations.

Alcon has a consensus price target of $84.96, suggesting a potential upside of 15.46%. Given Alcon's stronger consensus rating and higher probable upside, analysts plainly believe Alcon is more favorable than Innovative Eyewear.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Alcon
1 Sell rating(s)
6 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.63

Alcon has higher revenue and earnings than Innovative Eyewear.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$3.41MN/AN/AN/AN/A
Alcon$10.40B3.50$980M$1.3156.18

53.9% of Alcon shares are owned by institutional investors. 1.5% of Alcon shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Alcon has a net margin of 5.92% compared to Innovative Eyewear's net margin of 0.00%. Alcon's return on equity of 7.29% beat Innovative Eyewear's return on equity.

Company Net Margins Return on Equity Return on Assets
Innovative EyewearN/A N/A N/A
Alcon 5.92%7.29%5.09%

In the previous week, Alcon had 2 more articles in the media than Innovative Eyewear. MarketBeat recorded 3 mentions for Alcon and 1 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 0.88 beat Alcon's score of 0.48 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Innovative Eyewear
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alcon
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Alcon beats Innovative Eyewear on 11 of the 12 factors compared between the two stocks.

How does Innovative Eyewear compare to West Pharmaceutical Services?

Innovative Eyewear (NASDAQ:LUCYW) and West Pharmaceutical Services (NYSE:WST) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

West Pharmaceutical Services has a net margin of 16.98% compared to Innovative Eyewear's net margin of 0.00%. West Pharmaceutical Services' return on equity of 20.11% beat Innovative Eyewear's return on equity.

Company Net Margins Return on Equity Return on Assets
Innovative EyewearN/A N/A N/A
West Pharmaceutical Services 16.98%20.11%14.83%

93.9% of West Pharmaceutical Services shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

West Pharmaceutical Services has a consensus price target of $368.08, indicating a potential upside of 4.29%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts clearly believe West Pharmaceutical Services is more favorable than Innovative Eyewear.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
West Pharmaceutical Services
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.87

West Pharmaceutical Services has higher revenue and earnings than Innovative Eyewear.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$3.41MN/AN/AN/AN/A
West Pharmaceutical Services$3.07B8.08$493.70M$7.8145.19

In the previous week, West Pharmaceutical Services had 11 more articles in the media than Innovative Eyewear. MarketBeat recorded 12 mentions for West Pharmaceutical Services and 1 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 0.88 beat West Pharmaceutical Services' score of 0.86 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Innovative Eyewear
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
West Pharmaceutical Services
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

West Pharmaceutical Services beats Innovative Eyewear on 11 of the 12 factors compared between the two stocks.

Get Innovative Eyewear News Delivered to You Automatically

Sign up to receive the latest news and ratings for LUCYW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LUCYW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LUCYW vs. The Competition

MetricInnovative EyewearHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$5.89B$7.27B$12.76B
Dividend YieldN/A1.75%2.54%11.08%
P/E RatioN/A26.30270.6924.20
Price / SalesN/A80.78639.89109.35
Price / CashN/A33.2076.8953.23
Price / BookN/A6.2013.436.37
Net IncomeN/A$149.51M$3.46B$347.74M
7 Day PerformanceN/A0.87%2.15%0.06%
1 Month PerformanceN/A8.29%6.18%2.86%
1 Year PerformanceN/A7.70%24.96%17.13%

Innovative Eyewear Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LUCYW
Innovative Eyewear
N/A$0.04
flat
N/A-51.7%$0.00$3.41MN/A9
NXGLW
NEXGEL
N/A$0.02
-23.9%
N/A-96.2%$0.00$11.27MN/A10
WOK
WORK Medical Technology Group
0.9177 of 5 stars
$2.20
-5.6%
N/A-100.0%$0.00$9.85MN/A226
MDLN
Medline
3.8202 of 5 stars
$34.12
-2.2%
$47.42
+39.0%
N/A$46.99B$28.43B43.1945,000
ALC
Alcon
3.2049 of 5 stars
$73.68
+1.6%
$84.63
+14.9%
-7.0%$36.73B$10.40B56.2425,942

Related Companies and Tools


This page (NASDAQ:LUCYW) was last updated on 8/22/2026 by MarketBeat.com Staff.
From Our Partners